Polymyxin B Injection, Powder, For Solution
Product Images NDC 0143-9461

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 0143-9461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Polymyxin B For Injection Usp 1)

Chemical Structure (Polymyxin B For Injection Usp 1)
Chemical structure diagram depicting polymyxin B1 and polymyxin B2 components of Polymyxin B Sulfate. The diagram shows the sequence of amino acids and characteristic chemical groups with variable positions denoted by R groups (R=CH3 for polymyxin B1 and R=H for polymyxin B2).*
FDA Label Image

Unit Label (Polymyxin B For Injection Usp 2)

Unit Label (Polymyxin B For Injection Usp 2)
Label for Polymyxin B Injection, USP, 500,000 units per vial, provided by Hikma Pharmaceuticals USA Inc. The label specifies sterile, lyophilized powder for injection intended for hospital use only via intramuscular, intravenous, or intrathecal routes. It includes dosage warnings, storage instructions before and after reconstitution, and manufacturing details.*
FDA Label Image

Carton 10 (Polymyxin B For Injection Usp 3)

Carton 10 (Polymyxin B For Injection Usp 3)
Packaging label for Polymyxin B for Injection, USP, 500,000 units per vial, a powder for solution injection. The label indicates 10 sterile vials per package, manufactured by Hikma Pharmaceuticals USA Inc. The product is for hospital use only, administered intramuscularly, intravenously, or intrathecally. The label includes storage instructions and warnings.*
FDA Label Image

Carton 01 (Polymyxin B For Injection Usp 4)

Carton 01 (Polymyxin B For Injection Usp 4)
Packaging label for Polymyxin B for Injection, USP 500,000 units per vial, lyophilized powder for solution. The label states it is for hospital use only when prescribed for intramuscular, intravenous, and/or intrathecal administration. Manufactured by Hikma Pharmaceuticals USA Inc. Includes storage and reconstitution instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.